3004.90.92.38 - Containing olanzapine or its salts 🖩
Details
| Field | Value |
|---|---|
| Unit of Quantity | kg |
| General Rate of Duty (Column 1 - General) | Free |
| Special Rate of Duty (Column 1 - Special) | N/A |
| Column 2 Rate of Duty | 30% |
| Quota Quantity | N/A |
| Additional Duties | N/A |
Overview
This HTS category, 3004.90.92.38, specifically classifies pharmaceutical preparations containing olanzapine or its salts. Olanzapine is an atypical antipsychotic medication primarily used for the treatment of schizophrenia and bipolar disorder. These medicaments are intended for therapeutic or prophylactic uses and are presented in measured doses or retail packaging, aligning with the broader definition of goods under heading 3004.
This classification is distinguished from its sibling category, 3004.90.92.37, which is reserved for medicaments containing lorazepam or its salts. Lorazepam is a benzodiazepine primarily used for its anxiolytic, sedative, and anticonvulsant properties. Therefore, the key differentiator for this subcategory is the specific active pharmaceutical ingredient – olanzapine.
As this is a leaf node within the HTS, there are no further subcategories. Classification under 3004.90.92.38 is definitive when the product's active ingredient is confirmed to be olanzapine or its salts, and it meets the general requirements of heading 3004 regarding therapeutic or prophylactic use and presentation for retail sale.